Literature DB >> 25597482

Over-expression of miR-10b in NPC patients: correlation with LMP1 and Twist1.

Nesrine Allaya1, Abdelmajid Khabir, Tahia Sallemi-Boudawara, Noura Sellami, Jamel Daoud, Abdelmonem Ghorbel, Mounir Frikha, Ali Gargouri, Raja Mokdad-Gargouri, Wajdi Ayadi.   

Abstract

Aberrant expression of miR-10b has been described in many cancers but remains unexplored in nasopharyngeal carcinoma (NPC). Therefore, we aimed to study the miR-10b expression level in 43 NPC biopsies collected from Tunisian patients and three NPC xenografts. Then, we investigated the correlation between miR-10b expression and its upstream regulators LMP1/Twist1 as well as its adjacent gene HoxD4. We showed that miR-10b was significantly up-regulated in NPC biopsies compared to non-tumor nasopharyngeal tissues (fold change 153; p = 0.004) and associated with advanced clinical stage and young age at diagnosis (p = 0.005 and p = 0.011, respectively). In addition, over-expression of miR-10b was positively associated with the transcription factor Twist1 as well as the EBV oncoprotein LMP1 (fold change 6.32; p = 0.014, fold change 6.58; p = 0.01 respectively). Furthermore, higher level of miR-10b was observed in tumors with simultaneous expression of LMP1 and Twist1, compared to those expressing only Twist1 (fold change 2.49; p = 0.033). Meanwhile, the analysis of the link between miR-10b and its neighbor gene HoxD4 did not show any significant correlation (Fisher test p = 0.205; Mann-Whitney test p = 0.676). This study reports the first evidence of miR-10b over-expression in NPC patients. Furthermore, our findings can support hsa-miR-10b gene regulation through LMP1/Twist1 in NPC malignancy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25597482     DOI: 10.1007/s13277-014-3022-6

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  42 in total

1.  Contrasted frequencies of p53 accumulation in the two age groups of North African nasopharyngeal carcinomas.

Authors:  A Khabir; A Sellami; M Sakka; A M Ghorbel; J Daoud; M Frikha; M M Drira; P Busson; R Jlidi
Journal:  Clin Cancer Res       Date:  2000-10       Impact factor: 12.531

Review 2.  LMP1 expression is positively associated with metastasis of nasopharyngeal carcinoma: evidence from a meta-analysis.

Authors:  Yi Zhao; Yan Wang; Shan Zeng; Xinrong Hu
Journal:  J Clin Pathol       Date:  2011-10-29       Impact factor: 3.411

3.  Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia.

Authors:  H Karray; W Ayadi; L Fki; A Hammami; J Daoud; M M Drira; M Frikha; R Jlidi; J M Middeldorp
Journal:  J Med Virol       Date:  2005-04       Impact factor: 2.327

4.  miR-10b promotes migration and invasion in nasopharyngeal carcinoma cells.

Authors:  Xiao-Jin Sun; Hao Liu; Pei Zhang; Xu-Dong Zhang; Zhi-Wen Jiang; Chen-Chen Jiang
Journal:  Asian Pac J Cancer Prev       Date:  2013

5.  MicroRNA-10b induced by Epstein-Barr virus-encoded latent membrane protein-1 promotes the metastasis of human nasopharyngeal carcinoma cells.

Authors:  Gang Li; Zhengrong Wu; Ying Peng; Xiong Liu; Juan Lu; Lu Wang; Qiuhui Pan; Min-Liang He; Xiang-Ping Li
Journal:  Cancer Lett       Date:  2010-08-21       Impact factor: 8.679

6.  MicroRNAs and metastasis-related gene expression in Egyptian breast cancer patients.

Authors:  Mohamed M Hafez; Zeinab K Hassan; Abdel Rahman N Zekri; Ayman A Gaber; Salem S Al Rejaie; Mohamed M Sayed-Ahmed; Othman Al Shabanah
Journal:  Asian Pac J Cancer Prev       Date:  2012

Review 7.  [Nasopharyngeal carcinoma. Recent data].

Authors:  H Boussen; N Bouaouina; N Mokni-Baizig; A Gamoudi; L Chouchane; F Benna; A Ladgham
Journal:  Pathol Biol (Paris)       Date:  2005-02

8.  Epstein-Barr virus encoded LMP1 downregulates TCL1 oncogene through miR-29b.

Authors:  E Anastasiadou; F Boccellato; S Vincenti; P Rosato; I Bozzoni; L Frati; A Faggioni; C Presutti; P Trivedi
Journal:  Oncogene       Date:  2009-12-07       Impact factor: 9.867

9.  MicroRNAs modulate hematopoietic lineage differentiation.

Authors:  Chang-Zheng Chen; Ling Li; Harvey F Lodish; David P Bartel
Journal:  Science       Date:  2003-12-04       Impact factor: 47.728

10.  Comparison of treatment results between adult and juvenile nasopharyngeal carcinoma.

Authors:  N Lance Downing; Suzanne Wolden; Priscilla Wong; David W Petrik; Wendy Hara; Quynh-Thu Le
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-03-26       Impact factor: 7.038

View more
  6 in total

Review 1.  The fundamental role of miR-10b in metastatic cancer.

Authors:  Patrick Sheedy; Zdravka Medarova
Journal:  Am J Cancer Res       Date:  2018-09-01       Impact factor: 6.166

2.  Demethylation of miR-10b plays a suppressive role in ccRCC cells.

Authors:  Cheng He; Xiaokun Zhao; Hongyi Jiang; Zhaohui Zhong; Ran Xu
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 3.  The miRacle in Pancreatic Cancer by miRNAs: Tiny Angels or Devils in Disease Progression.

Authors:  Zuhair Hawa; Inamul Haque; Arnab Ghosh; Snigdha Banerjee; LaCoiya Harris; Sushanta K Banerjee
Journal:  Int J Mol Sci       Date:  2016-05-26       Impact factor: 5.923

4.  Role of Epstein-Barr Virus in the Development of Nasopharyngeal Carcinoma.

Authors:  Hui Zhang; Jing Wang; Dan Yu; Yan Liu; Kai Xue; Xue Zhao
Journal:  Open Med (Wars)       Date:  2017-06-03

5.  Systematic review and meta-analysis of prognostic microRNA biomarkers for survival outcome in nasopharyngeal carcinoma.

Authors:  Shanthi Sabarimurugan; Chellan Kumarasamy; Siddhartha Baxi; Arikketh Devi; Rama Jayaraj
Journal:  PLoS One       Date:  2019-02-08       Impact factor: 3.240

6.  Identification and Validation of Circulating MicroRNA Signatures for Breast Cancer Early Detection Based on Large Scale Tissue-Derived Data.

Authors:  Xiaokang Yu; Jinsheng Liang; Jiarui Xu; Xingsong Li; Shan Xing; Huilan Li; Wanli Liu; Dongdong Liu; Jianhua Xu; Lizhen Huang; Hongli Du
Journal:  J Breast Cancer       Date:  2018-12-10       Impact factor: 3.588

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.